CT分期时机与患者因素对真性cN+膀胱癌检出率的影响
这项回顾性多中心研究分析了183例cN+ M0膀胱癌患者,按TURBT与CT分期的时间间隔分为三组,评估分期准确性和预测病理淋巴结状态的因素。结果显示,49%的患者在根治性膀胱切除术后为pN0,分期时机与病理淋巴结状态无关,而TURBT时的淋巴血管侵犯是唯一与pN状态相关的因素。
要点
- CT分期时机(TURBT前、后30天内或后30天以上)与病理淋巴结状态无关(所有P>0.05)。
- cN+患者中49%术后为pN0,总体临床与病理淋巴结状态一致率仅23%。
核心结论
- CT分期时机与cN+膀胱癌的病理淋巴结转移无关,TURBT后分期不增加假阳性淋巴结发现。
- 淋巴血管侵犯是TURBT时唯一与根治性膀胱切除术后病理淋巴结转移相关的因素。
研究设计与样本
- 回顾性多中心研究,纳入183例经CT分期为cN+ M0且接受 upfront 根治性膀胱切除加盆腔淋巴结清扫的膀胱癌患者。
- 按TURBT与CT分期间隔分为三组:TURBT前、TURBT后30天内、TURBT后超过30天。
主要发现
- 183例cN+患者中,90例(49%)在根治性膀胱切除术后为pN0。
- 三组pN0病例数分别为40例(TURBT前)、36例(TURBT后30天内)、14例(TURBT后超过30天)(P=0.2)。
- 病理降期最常见于cN1(22%)和cN2(20%)疾病,总体一致率为23%。
临床怎么用
- 对于cN+膀胱癌,CT分期可在TURBT前或后进行,不影响淋巴结分期准确性。
- TURBT时发现淋巴血管侵犯提示术后病理淋巴结阳性风险增高,可辅助临床决策。
局限性
- 多中心回顾性设计。
- 仅纳入临床淋巴结阳性患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To evaluate whether computed tomography (CT) scans should be performed before or after transurethral resection of bladder tumour (TURBT) for accurate lymph node staging in clinically lymph node-positive bladder cancer (BCa). Additionally, to identify patient factors that can aid in predicting lymph node metastasis. PATIENTS AND METHODS: In this retrospective, multicentre study, we analysed patients with cN+ M0 BCa staged by CT and treated with upfront radical cystectomy (RC) and pelvic lymph node dissection. We stratified patients by the interval between TURBT and CT into three groups: (1) before TURBT; (2) within 30 days after TURBT; and (3) more than 30 days post-TURBT. Staging accuracy, defined as concordance between clinical and pathological lymph node status, was evaluated. We utilised logistic regression analyses to identify patient factors, including the optimal timing of staging, in predicting pathological lymph node status at RC. RESULTS: Among 183 patients with cN+ disease, 90 (49%) had pN0 disease at RC. Of these, 40, 36 and 14 were staged before TURBT, within 30 days after TURBT, and more than 30 days post-TURBT, respectively (P = 0.2). Pathological downstaging was most common in cN1 (22%) and cN2 (20%) disease. The overall concordance rate was 23%. The timing of staging did not correlate with pathological lymph node status on logistic regression (all P > 0.05). Lymphovascular invasion (LVI) at TURBT was associated with pN status (odds ratio 4.25, confidence interval 2.02-9.34; P < 0.001) at RC. CONCLUSION: Overall, we found no association between the timing of CT-based staging and pathological lymph node metastases in cN+ BCa. The data suggest that performing a TURBT prior to staging does not increase the finding of false-positive nodes on imaging. LVI was the only factor at the time of TURBT associated with pathological lymph node metastasis at RC. Limitations include the multicentre retrospective design and the inclusion of only patients with clinically node-positive disease.
引用
- von Deimling M, Furrer M, Bianchi A, et al. Impact of timing of computed tomography staging and patient factors on the detection of 'true' cN+ bladder cancer. BJU Int. 2025. PMID: 40631580. doi:10.1111/bju.16851
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。